Skip to main content
. 2017 Apr 27;8(25):41518–41528. doi: 10.18632/oncotarget.17456

Figure 4.

Figure 4

(A) Positive LR and 95% confidence intervals for studies assessing the diagnostic value of 18F-FDG PET and PET/CT in patients with PCNSL. (B) Negative LR and 95% confidence intervals for studies assessing the diagnostic value of 18F-FDG PET and PET/CT in patients with PCNSL. *The diamond represents the 95% CI of the pooled estimate.